| Breakdown | TTM | Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 | Jan 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 7.79B | 5.77B | 5.51B | 5.92B | 4.46B | 2.97B |
| Gross Profit | 3.95B | 2.38B | 2.29B | 2.99B | 2.06B | 1.49B |
| EBITDA | 4.37B | 651.60M | 850.70M | 1.65B | 901.10M | 388.60M |
| Net Income | 2.47B | -885.00M | -933.40M | -163.50M | -421.00M | -277.30M |
Balance Sheet | ||||||
| Total Assets | 21.58B | 20.20B | 21.23B | 22.52B | 22.11B | 10.76B |
| Cash, Cash Equivalents and Short-Term Investments | 2.71B | 948.30M | 950.80M | 911.00M | 613.50M | 748.47M |
| Total Debt | 5.03B | 4.34B | 4.40B | 4.74B | 4.73B | 1.33B |
| Total Liabilities | 7.52B | 6.78B | 6.40B | 6.88B | 6.41B | 2.33B |
| Stockholders Equity | 14.06B | 13.43B | 14.83B | 15.64B | 15.70B | 8.44B |
Cash Flow | ||||||
| Free Cash Flow | 1.58B | 1.39B | 1.02B | 1.07B | 632.40M | 697.80M |
| Operating Cash Flow | 1.89B | 1.68B | 1.37B | 1.29B | 819.30M | 817.30M |
| Investing Cash Flow | 2.15B | -300.70M | -350.50M | -328.40M | -3.75B | -119.60M |
| Financing Cash Flow | -2.19B | -1.38B | -980.20M | -662.90M | 2.79B | -596.80M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | $70.63B | 28.60 | 18.04% | 0.28% | 44.95% | ― | |
73 Outperform | $1.51T | 67.06 | 31.05% | 0.69% | 23.87% | 285.84% | |
67 Neutral | $57.36B | 28.39 | 21.01% | 1.79% | -6.81% | -23.16% | |
64 Neutral | $26.19B | 199.16 | 1.47% | ― | -16.13% | -81.06% | |
64 Neutral | $29.39B | 180.31 | 0.93% | 1.28% | -17.33% | -76.71% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
58 Neutral | $40.21B | -258.11 | -1.09% | 2.79% | -23.36% | -131.15% |